Synthes sees recovery in Europe during promising Q4
This article was originally published in Clinica
Orthopaedic firm Synthes today posted healthy sales growth across all geographies for the fourth quarter of 2010. The results reflect the strong growth which has also been reported by Synthes’s rivals – such as Zimmer, Stryker and Smith & Nephew – and support the view that the ortho market is recovering.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals